Company Number: 13583670

Analysis Date: 2025-07-29 16:43 UTC

Financial Health Assessment of GCRE LIMITED

---

1. Financial Health Score: B

Explanation:
GCRE LIMITED shows a solid equity base supported by substantial shareholder funding from the Welsh Government, which acts as a financial lifeline for the company. However, the company is currently operating at a loss and heavily reliant on external funding, which impacts profitability and financial independence. The going concern assumption is supported by government backing, but the company’s negative retained earnings and reliance on capital injections suggest caution. Overall, the company is financially stable but with symptoms indicating early-stage operational loss and dependency.

---

2. Key Vital Signs

Metric	Value (Year ended 31 March 2024)	Interpretation
Shareholders’ Funds (Equity)	£29,575,617	Strong equity base, indicating solid net worth.
Retained Earnings	(£2,024,483) (negative)	Accumulated losses, indicating operational losses.
Net Assets	£29,575,617	Positive net assets, good financial foundation.
Loss for the Year	(£996,760)	Operating loss, reflecting costs exceed income.
Cash and Cash Equivalents	£4,392,460	Healthy cash reserves for operational liquidity.
Net Current Assets	£1,021,604	Positive working capital, suggesting ability to meet short-term obligations.
Property, Plant & Equipment	£48,554,013	Significant investment in long-term assets, typical for development projects.
Deferred Revenue (Non-current)	£20,000,000	Indicates advance funding/receipts, showing future income secured.
Share Capital Issued During Year	£13,000,000	Significant capital injection, sustaining operations.

---

3. Diagnosis

• Strong Capital Backbone: The company has a robust capital structure with £31.6 million in share capital issued and shareholders’ funds nearing £30 million. This acts like a strong heart pumping necessary funds into the business. The Welsh Government’s backing is akin to a vital lifeline, providing confidence in the company’s ability to meet obligations and continue operations.

• Operational Losses - Symptoms of Growing Pains: The loss of nearly £1 million in the latest year and negative retained earnings indicate the company is in an investment and development phase, not yet profitable. This is a common symptom in early-stage infrastructure and development projects, reflecting high upfront costs and ongoing expenses before revenue generation ramps up.

• Healthy Cash Flow and Liquidity: Cash reserves of over £4.3 million and positive net current assets indicate the company has healthy liquidity — a good pulse indicating it can pay current bills and invest in ongoing activities without immediate financial distress.

• Significant Investment in Fixed Assets: The increase in property, plant and equipment from £30.5 million to £48.5 million shows ongoing capital expenditure, consistent with the company’s development of building projects. This is a positive sign of growth and asset accumulation, although it also ties up capital in long-term assets.

• Deferred Revenue as a Funding Buffer: Large deferred revenue (£20 million non-current) suggests the company has secured funding or contracts in advance, providing a financial cushion and future income visibility. This is similar to a patient having a steady supply of medication—good for stabilizing health during recovery.

• Governance and Stability: The board consists of experienced directors, with no red flags on director conduct. The company is current with filings and maintains compliance, indicating good administrative health.

---

4. Recommendations

• Monitor Operational Efficiency: Focus on managing operating expenses and improving operational efficiency to reduce losses. This may include tighter project cost controls and enhanced revenue generation strategies as the development progresses.

• Leverage Government Support Strategically: Continue leveraging Welsh Government backing but develop a long-term plan to reduce dependency on capital injections and move towards self-sustainability.

• Asset Utilization Review: Conduct regular assessments of property, plant, and equipment to ensure assets are optimally utilized and not idle, avoiding impairment risks.

• Cash Flow Management: Maintain strong cash flow monitoring to ensure liquidity remains healthy, especially as capital expenditures continue.

• Prepare for Profitability: Develop detailed forecasts and milestones for moving from loss-making to profitable operations, including timelines for generating operating income from the facility.

• Stakeholder Communication: Maintain transparent communication with shareholders and stakeholders about financial health, progress, and challenges to sustain confidence.

---

Executive Summary